+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Brachytherapy - Global Strategic Business Report

  • PDF Icon

    Report

  • 184 Pages
  • June 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 1056065
Description Jump to:
The global market for Brachytherapy was estimated at US$1.8 Billion in 2024 and is projected to reach US$2.3 Billion by 2030, growing at a CAGR of 4.3% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Brachytherapy market.

Global Brachytherapy Market - Key Trends and Drivers Summarized

Why Is Brachytherapy a Game-Changer in Cancer Treatment?

Brachytherapy is revolutionizing the field of cancer treatment with its precise, localized approach to delivering radiation therapy. This method involves placing radioactive sources directly into or near a tumor, allowing for a high dose of radiation to target cancerous cells while minimizing exposure to surrounding healthy tissues. Brachytherapy is particularly effective for treating various types of cancer, including prostate, cervical, breast, and skin cancers. Its ability to deliver concentrated radiation doses makes it an ideal option for tumors that are difficult to treat with external beam radiation therapy. Moreover, brachytherapy procedures are typically less invasive and can be performed on an outpatient basis, leading to quicker recovery times and reduced hospital stays. The precision and effectiveness of brachytherapy have made it a preferred choice for many oncologists and patients, significantly improving cancer treatment outcomes.

How Are Technological Innovations Enhancing Brachytherapy?

Technological advancements are at the forefront of enhancing brachytherapy, making it more effective and accessible. One of the most significant innovations is the development of advanced imaging techniques, such as MRI and CT scans, which provide detailed visualization of the tumor and surrounding tissues. These imaging technologies enable precise placement of radioactive sources, ensuring optimal treatment delivery. Additionally, advancements in computer software and treatment planning systems have revolutionized brachytherapy by allowing oncologists to create highly customized treatment plans based on the specific characteristics of each tumor. Innovations in radioactive source materials, such as the use of high-dose-rate (HDR) brachytherapy, have further improved treatment efficacy and reduced procedure times. These technological strides not only enhance the accuracy and effectiveness of brachytherapy but also expand its applicability to a broader range of cancers, solidifying its role as a critical component of modern cancer treatment.

What Are the Key Applications and Benefits of Brachytherapy?

Brachytherapy`s key applications span a wide range of cancers, offering significant benefits over traditional radiation therapy methods. For prostate cancer, brachytherapy is a highly effective treatment option, providing excellent long-term control with minimal side effects. It is also a standard treatment for cervical cancer, where it can be used in conjunction with external beam radiation therapy to enhance treatment efficacy. In breast cancer treatment, brachytherapy is often employed as a part of breast-conserving therapy, allowing for the delivery of targeted radiation to the tumor bed while preserving healthy breast tissue. Additionally, brachytherapy is used in the treatment of skin cancer, offering a non-invasive alternative to surgery with high cure rates. The primary benefits of brachytherapy include its precision, reduced treatment times, and lower risk of damage to surrounding healthy tissues. These advantages contribute to improved patient outcomes and quality of life, making brachytherapy a valuable tool in the fight against cancer.

What Factors Are Driving the Growth in the Brachytherapy Market?

The growth in the brachytherapy market is driven by several factors. Technological advancements in imaging and treatment planning systems have significantly enhanced the precision and effectiveness of brachytherapy, leading to increased adoption by healthcare providers. The rising incidence of cancer worldwide has expanded the demand for effective and minimally invasive treatment options. Additionally, the growing preference for outpatient procedures and the associated cost savings are driving the market for brachytherapy. Regulatory approvals and favorable reimbursement policies are also supporting market growth by making brachytherapy more accessible to patients. Moreover, ongoing research and development efforts are leading to the introduction of new and improved radioactive source materials, further boosting the market. Strategic collaborations and partnerships among key industry players are accelerating innovation and commercialization of advanced brachytherapy solutions. These factors collectively ensure a robust growth trajectory for the brachytherapy market, highlighting its critical role in modern cancer treatment.

SCOPE OF STUDY:

The report analyzes the Brachytherapy market in terms of units by the following Segments, and Geographic Regions/Countries:
  • Segments: Type (High Dose Rate, Low Dose Rate); Application (Prostate Cancer, Gynecological Cancer, Breast Cancer, Other Applications)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the High Dose Rate segment, which is expected to reach US$1.6 Billion by 2030 with a CAGR of a 3.7%. The Low Dose Rate segment is also set to grow at 5.6% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $486.9 Million in 2024, and China, forecasted to grow at an impressive 7.2% CAGR to reach $495.3 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Brachytherapy Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Brachytherapy Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Brachytherapy Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Bard Medical Division, Best Medical International, Inc., Best Vascular, Inc., Boston Scientific Corporation, Carl Zeiss Meditec AG and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 24 companies featured in this Brachytherapy market report include:

  • Bard Medical Division
  • Best Medical International, Inc.
  • Best Vascular, Inc.
  • Boston Scientific Corporation
  • Carl Zeiss Meditec AG
  • Elekta AB
  • Sirtex Medical Limited
  • Sun Nuclear Corporation
  • Theragenics Corporation
  • Varian Medical Systems, Inc.
  • Xoft, Inc.

This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:

  • Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
  • Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
  • Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
  • Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
  • Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
  • Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
  • Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Tariff Impact on Global Supply Chain Patterns
Global Economic Update
Brachytherapy - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increasing Incidence of Cancer Propels Growth in Brachytherapy Market
Advances in Radiation Therapy Technologies Strengthen Business Case for Brachytherapy
Rising Adoption of Minimally Invasive Treatments Expands Addressable Market Opportunity
Technological Innovations in Imaging and Delivery Systems Generate Market Opportunities
Growth of Outpatient and Ambulatory Care Drives Demand for Brachytherapy Solutions
Regulatory Approvals and Clinical Guidelines Propel Demand for Brachytherapy Procedures
Increasing Focus on Targeted Therapy Sustains Growth in Brachytherapy Market
Expansion of Healthcare Infrastructure and Cancer Treatment Centers Drives Adoption
Strategic Collaborations and Partnerships Accelerate Innovation in Brachytherapy Technologies
Growing Emphasis on Personalized Treatment Plans Generates Demand for Customized Brachytherapy
Demand for High-Precision and Effective Cancer Treatments Propels Growth
Rising Use of Brachytherapy in Prostate and Gynecological Cancers Drives Market Expansion
Global Healthcare Advancements and Increased Access to Cancer Care Generate Opportunities in Brachytherapy Market
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Brachytherapy Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Brachytherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 3: World Historic Review for Brachytherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 4: World 15-Year Perspective for Brachytherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for High Dose Rate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 6: World Historic Review for High Dose Rate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 7: World 15-Year Perspective for High Dose Rate by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Low Dose Rate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 9: World Historic Review for Low Dose Rate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 10: World 15-Year Perspective for Low Dose Rate by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 12: World Historic Review for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 13: World 15-Year Perspective for Prostate Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Gynecological Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 15: World Historic Review for Gynecological Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 16: World 15-Year Perspective for Gynecological Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 18: World Historic Review for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 19: World 15-Year Perspective for Breast Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 22: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Brachytherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 23: USA Recent Past, Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 24: USA Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 25: USA 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2015, 2025 & 2030
TABLE 26: USA Recent Past, Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 27: USA Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 28: USA 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2015, 2025 & 2030
CANADA
TABLE 29: Canada Recent Past, Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 30: Canada Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 31: Canada 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2015, 2025 & 2030
TABLE 32: Canada Recent Past, Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 33: Canada Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 34: Canada 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2015, 2025 & 2030
JAPAN
Brachytherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 35: Japan Recent Past, Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 36: Japan Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 37: Japan 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2015, 2025 & 2030
TABLE 38: Japan Recent Past, Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 39: Japan Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 40: Japan 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2015, 2025 & 2030
CHINA
Brachytherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 41: China Recent Past, Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 42: China Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 43: China 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2015, 2025 & 2030
TABLE 44: China Recent Past, Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 45: China Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 46: China 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2015, 2025 & 2030
EUROPE
Brachytherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 47: Europe Recent Past, Current & Future Analysis for Brachytherapy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 48: Europe Historic Review for Brachytherapy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 49: Europe 15-Year Perspective for Brachytherapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
TABLE 50: Europe Recent Past, Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 51: Europe Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 52: Europe 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2015, 2025 & 2030
TABLE 53: Europe Recent Past, Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 54: Europe Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 55: Europe 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2015, 2025 & 2030
FRANCE
Brachytherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 56: France Recent Past, Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 57: France Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 58: France 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2015, 2025 & 2030
TABLE 59: France Recent Past, Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 60: France Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 61: France 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2015, 2025 & 2030
GERMANY
Brachytherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 62: Germany Recent Past, Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 63: Germany Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 64: Germany 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2015, 2025 & 2030
TABLE 65: Germany Recent Past, Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 66: Germany Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 67: Germany 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2015, 2025 & 2030
ITALY
TABLE 68: Italy Recent Past, Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 69: Italy Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 70: Italy 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2015, 2025 & 2030
TABLE 71: Italy Recent Past, Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 72: Italy Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 73: Italy 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2015, 2025 & 2030
UNITED KINGDOM
Brachytherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 74: UK Recent Past, Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 75: UK Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 76: UK 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2015, 2025 & 2030
TABLE 77: UK Recent Past, Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 78: UK Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 79: UK 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2015, 2025 & 2030
SPAIN
TABLE 80: Spain Recent Past, Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 81: Spain Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 82: Spain 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2015, 2025 & 2030
TABLE 83: Spain Recent Past, Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 84: Spain Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 85: Spain 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2015, 2025 & 2030
RUSSIA
TABLE 86: Russia Recent Past, Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 87: Russia Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 88: Russia 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2015, 2025 & 2030
TABLE 89: Russia Recent Past, Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 90: Russia Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 91: Russia 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2015, 2025 & 2030
REST OF EUROPE
TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 93: Rest of Europe Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 94: Rest of Europe 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2015, 2025 & 2030
TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 96: Rest of Europe Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 97: Rest of Europe 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2015, 2025 & 2030
ASIA-PACIFIC
Brachytherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Brachytherapy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 99: Asia-Pacific Historic Review for Brachytherapy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 100: Asia-Pacific 15-Year Perspective for Brachytherapy by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 102: Asia-Pacific Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 103: Asia-Pacific 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2015, 2025 & 2030
TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 105: Asia-Pacific Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 106: Asia-Pacific 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2015, 2025 & 2030
AUSTRALIA
Brachytherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
INDIA
Brachytherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
SOUTH KOREA
REST OF ASIA-PACIFIC
LATIN AMERICA
Brachytherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
ARGENTINA
BRAZIL
MEXICO
REST OF LATIN AMERICA
MIDDLE EAST
Brachytherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
IRAN
ISRAEL
SAUDI ARABIA
UNITED ARAB EMIRATES
REST OF MIDDLE EAST
AFRICA
Brachytherapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Bard Medical Division
  • Best Medical International, Inc.
  • Best Vascular, Inc.
  • Boston Scientific Corporation
  • Carl Zeiss Meditec AG
  • Elekta AB
  • Sirtex Medical Limited
  • Sun Nuclear Corporation
  • Theragenics Corporation
  • Varian Medical Systems, Inc.
  • Xoft, Inc.

Table Information

Report AttributeDetails
No. of Pages184
PublishedJune 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.8 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.3 Billion
Compound Annual Growth Rate4.3%
Regions CoveredGlobal

Related Topics

Related Reports

Brachytherapy Market by Dose Rate, End User, Product, Treatment Type, Application - Global Forecast to 2030 - Product Image

Brachytherapy Market by Dose Rate, End User, Product, Treatment Type, Application - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global
From
Brachytherapy Market Report 2025 - Product Image

Brachytherapy Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Brachytherapy Treatment Planning Systems - Global Strategic Business Report - Product Image

Brachytherapy Treatment Planning Systems - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Brachytherapy Treatment Planning System Market by Application, Treatment Type, End User, Component - Global Forecast to 2030 - Product Image

Brachytherapy Treatment Planning System Market by Application, Treatment Type, End User, Component - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
Brachytherapy Devices Market Report 2025 - Product Image

Brachytherapy Devices Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.